chr22-19964374-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000754.4(COMT):​c.615+75G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.188 in 1,604,012 control chromosomes in the GnomAD database, including 29,376 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.18 ( 2595 hom., cov: 33)
Exomes 𝑓: 0.19 ( 26781 hom. )

Consequence

COMT
NM_000754.4 intron

Scores

1
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2O:1

Conservation

PhyloP100: 0.261

Publications

21 publications found
Variant links:
Genes affected
COMT (HGNC:2228): (catechol-O-methyltransferase) Catechol-O-methyltransferase catalyzes the transfer of a methyl group from S-adenosylmethionine to catecholamines, including the neurotransmitters dopamine, epinephrine, and norepinephrine. This O-methylation results in one of the major degradative pathways of the catecholamine transmitters. In addition to its role in the metabolism of endogenous substances, COMT is important in the metabolism of catechol drugs used in the treatment of hypertension, asthma, and Parkinson disease. COMT is found in two forms in tissues, a soluble form (S-COMT) and a membrane-bound form (MB-COMT). The differences between S-COMT and MB-COMT reside within the N-termini. Several transcript variants are formed through the use of alternative translation initiation sites and promoters. [provided by RefSeq, Sep 2008]
COMT Gene-Disease associations (from GenCC):
  • paroxysmal dyskinesia
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0045391023).
BP6
Variant 22-19964374-G-C is Benign according to our data. Variant chr22-19964374-G-C is described in ClinVar as Benign. ClinVar VariationId is 828955.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.228 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000754.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COMT
NM_000754.4
MANE Select
c.615+75G>C
intron
N/ANP_000745.1
COMT
NM_001135161.2
c.615+75G>C
intron
N/ANP_001128633.1
COMT
NM_001135162.2
c.615+75G>C
intron
N/ANP_001128634.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COMT
ENST00000361682.11
TSL:1 MANE Select
c.615+75G>C
intron
N/AENSP00000354511.6
COMT
ENST00000406520.7
TSL:1
c.615+75G>C
intron
N/AENSP00000385150.3
COMT
ENST00000449653.5
TSL:1
c.465+75G>C
intron
N/AENSP00000416778.1

Frequencies

GnomAD3 genomes
AF:
0.180
AC:
27352
AN:
152112
Hom.:
2594
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.146
Gnomad AMI
AF:
0.258
Gnomad AMR
AF:
0.197
Gnomad ASJ
AF:
0.116
Gnomad EAS
AF:
0.122
Gnomad SAS
AF:
0.240
Gnomad FIN
AF:
0.289
Gnomad MID
AF:
0.152
Gnomad NFE
AF:
0.182
Gnomad OTH
AF:
0.158
GnomAD2 exomes
AF:
0.201
AC:
48457
AN:
240914
AF XY:
0.201
show subpopulations
Gnomad AFR exome
AF:
0.150
Gnomad AMR exome
AF:
0.240
Gnomad ASJ exome
AF:
0.118
Gnomad EAS exome
AF:
0.117
Gnomad FIN exome
AF:
0.298
Gnomad NFE exome
AF:
0.187
Gnomad OTH exome
AF:
0.202
GnomAD4 exome
AF:
0.188
AC:
273449
AN:
1451782
Hom.:
26781
Cov.:
30
AF XY:
0.190
AC XY:
137013
AN XY:
722302
show subpopulations
African (AFR)
AF:
0.145
AC:
4843
AN:
33302
American (AMR)
AF:
0.239
AC:
10475
AN:
43872
Ashkenazi Jewish (ASJ)
AF:
0.116
AC:
3011
AN:
25990
East Asian (EAS)
AF:
0.122
AC:
4820
AN:
39500
South Asian (SAS)
AF:
0.243
AC:
20799
AN:
85664
European-Finnish (FIN)
AF:
0.297
AC:
15549
AN:
52388
Middle Eastern (MID)
AF:
0.179
AC:
1031
AN:
5756
European-Non Finnish (NFE)
AF:
0.183
AC:
202142
AN:
1105220
Other (OTH)
AF:
0.179
AC:
10779
AN:
60090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
13038
26076
39114
52152
65190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7162
14324
21486
28648
35810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.180
AC:
27361
AN:
152230
Hom.:
2595
Cov.:
33
AF XY:
0.184
AC XY:
13656
AN XY:
74414
show subpopulations
African (AFR)
AF:
0.146
AC:
6065
AN:
41554
American (AMR)
AF:
0.198
AC:
3019
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.116
AC:
401
AN:
3470
East Asian (EAS)
AF:
0.122
AC:
631
AN:
5172
South Asian (SAS)
AF:
0.240
AC:
1158
AN:
4826
European-Finnish (FIN)
AF:
0.289
AC:
3066
AN:
10594
Middle Eastern (MID)
AF:
0.150
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
0.182
AC:
12410
AN:
68012
Other (OTH)
AF:
0.157
AC:
332
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1153
2306
3459
4612
5765
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
308
616
924
1232
1540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.178
Hom.:
796
Bravo
AF:
0.171
TwinsUK
AF:
0.180
AC:
669
ALSPAC
AF:
0.186
AC:
715
ExAC
AF:
0.196
AC:
23739
Asia WGS
AF:
0.168
AC:
587
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 10, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Tramadol response Other:1
Apr 28, 2018
Bruce Budowle Laboratory, University of North Texas Health Science Center
Significance:drug response
Review Status:no assertion criteria provided
Collection Method:research

T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
4.3
DANN
Benign
0.95
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.073
N
LIST_S2
Benign
0.24
T
MetaRNN
Benign
0.0045
T
MetaSVM
Benign
-1.1
T
PhyloP100
0.26
PROVEAN
Benign
-0.36
N
REVEL
Benign
0.080
Sift
Uncertain
0.017
D
Sift4G
Benign
0.078
T
Polyphen
0.0010
B
Vest4
0.021
MutPred
0.19
Loss of ubiquitination at K230 (P = 0.0011)
ClinPred
0.0032
T
GERP RS
-1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4646315; hg19: chr22-19951897; COSMIC: COSV52889132; COSMIC: COSV52889132; API